Cases & Deals

ABN AMRO and Crédit Agricole invest in Xention Discovery

Clients ABN AMRO Capital and Crédit Agricole Private Equity

Jones Day counseled ABN AMRO Capital and Crédit Agricole Private Equity in connection with the purchase of $20 million of Series B Common Stock in a private placement by Xention Discovery Limited, a company that engages in the discovery and development of ion channel-modulating drugs in the United Kingdom.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.